News
(2)April 2026
ACADIA Pharmaceuticals 2024 Annual Report Highlights Strategy and Performance
# 🧾 What This Document Is This is ACADIA Pharmaceuticals' **Annual Report to Shareholders (ARS)**. Think of it as the company's yearly "highlight reel" sent directly to its investors. It's designed to be more visual and narrative than a strict regulatory filing, summarizing performance, strategy, a
ACADIA Seeks Shareholder Vote on 5.2 Million Share Equity Plan Expansion
# 🧾 What This Document Is This is a **Definitive Proxy Statement (DEF 14A)** for **ACADIA Pharmaceuticals Inc.** Think of it as the official invitation and instruction manual for the company's annual shareholder meeting. It tells shareholders what will be voted on, provides background on the compan
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.